The placebo effect is a real physiological event. Its reputation as a trick played on a suggestible mind is wrong. When a person expects relief, has been conditioned by past treatment, and is cared for with attention, the body's own regulatory systems switch on. A placebo releases dopamine in Parkinson's disease and the body's own opioids against pain, accounts for much of the improvement people get from antidepressants, and eases irritable bowel, chronic back pain and cancer-related fatigue in careful trials even when the person is told outright that the pill contains no drug.
The same mechanism runs in reverse as the nocebo effect, where a negative expectation produces symptoms. What a placebo moves is how a person feels and functions: it does not shrink a tumor, lower a blood sugar reading, or knit a broken bone. Reading that line is most of what it takes to use the idea well.
Findings & Outcomes
What It Is
A placebo response is an improvement produced by the context of a treatment: the pill, the ritual, the clinician's attention, and the expectation of getting better. Two mechanisms drive it. Expectation changes what the nervous system does next, so believing a treatment will help is itself part of the treatment. Conditioning is learned: pairing a treatment with a real drug effect enough times teaches the body to reproduce part of that effect on its own. Both run through the whole meaning of care, which is why an attentive encounter and a clear, positive explanation change the outcome and are part of the medicine.
What a placebo moves is symptoms and subjective states. It is large for what the brain generates and modulates: pain, depression, anxiety, nausea, fatigue, irritable bowel, and the motor symptoms of Parkinson's disease. It has no lever on the disease underneath.
A placebo moves how a person feels and functions. It does not shrink a tumor, lower a blood sugar reading, or knit a broken bone.
One distinction clears up most of the confusion, between the placebo response and the placebo effect:
- The placebo response is everything that improves after an inert treatment. It includes the illness running its natural course and the tendency of extreme symptoms to drift back toward average, an artifact called regression to the mean.
- The placebo effect is the part caused specifically by expectation and context.
Good research isolates the effect by comparing a placebo group against an untreated group. When it does, an effect remains that natural history and regression to the mean cannot account for.
What the Evidence Shows
The open-label placebo trials are the clearest surprise. People given a pill openly described as inert, with no drug in it, still improved more than people given no treatment.
- In irritable bowel syndrome, patients told plainly their pills were placebos scored higher on the IBS Global Improvement Scale over three weeks than an untreated group, 5.0 versus 3.9.
- In chronic low back pain added to usual care, composite pain dropped 1.5 points on a 0 to 10 scale, against 0.2 with usual care alone.
- In cancer survivors, fatigue fell by about 29%.
Pooling 11 of these trials across conditions gave a significant overall effect, a standardized mean difference of 0.72. Telling people the pill is inert does not remove the benefit. These trials are mostly small, short, and measured by self-reported scales, so they show the effect exists without deception without fixing its long-term size, and the benefit is clearest for brain-mediated symptoms.
How big the placebo component is depends entirely on what is measured, and depression shows the range. In an analysis of the antidepressant trial data submitted to US regulators, most of the improvement people got on the drugs was matched by improvement on placebo. The drug pulled clearly ahead only in the most severely depressed patients, mostly because the placebo response was weaker in that group. This measures how large the placebo component is; it is not a verdict on whether the drugs work.
The mechanisms are concrete, mapped in the nervous, endocrine and immune systems. Each finding below is graded at the strength of its own evidence.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Mood & stress
Placebo matched most of the antidepressant response, the drug ahead mainly in severe depression
In depression trials, most of the improvement people got on antidepressants also happened on placebo. The drug clearly outperformed placebo mainly in the most severe cases, where the placebo response was smaller.
A meta-analysis of clinical-trial data submitted to the US regulator (including unpublished trials) examined how the antidepressant-versus-placebo difference varied with baseline severity. Both drug and placebo groups improved substantially; the difference between them met a standard threshold for clinical significance only at the highest severity levels, and this widening gap was driven mostly by a diminishing placebo response in severe depression rather than a rising drug response. The finding measures how large the placebo component of the response is, not that antidepressants are ineffective.
The study · 1
Kirsch et al. 2008, PLoS Med · PLoS Med
How it works
Blocking opioid receptors with naloxone cancels much of placebo pain relief
A lot of placebo pain relief runs on the body's own opioids. Block those receptors with a drug and the relief largely disappears; brain scans show the placebo using the same pain-control circuit as morphine.
Two complementary lines establish the mechanism. In post-surgical dental pain, administering naloxone (an opioid receptor antagonist) abolished much of the analgesia produced by placebo, implicating endogenous opioids (Levine 1978). Decades later, functional MRI combined with naloxone showed that placebo analgesia activates the descending opioidergic pain-modulatory system, from the rostral anterior cingulate cortex through the periaqueductal gray to the rostral ventromedial medulla, and that naloxone reduces both the behavioral and the neural placebo response (Eippert 2009). Together they show placebo pain relief is a real, opioid-dependent neurobiological process.
The studies · 2
Levine, Gordon & Fields 1978, Lancet · Lancet
Eippert et al. 2009, Neuron · Neuron
Open-label placebo helped on average across 11 pooled randomized trials
Pulling together the trials where people knew they were taking a placebo, the pills still helped on average across a range of conditions.
A systematic review and meta-analysis reviewed 13 randomized controlled trials of open-label placebo (openly described inert treatment) and pooled 11 of them across a spread of conditions and found a significant positive effect overall in favor of open-label placebo compared with no treatment. Effects were clearest for self-reported, brain-mediated symptoms. The authors note the trials are mostly small, short, and heterogeneous, so the pooled estimate establishes that the effect is real and reproducible without fixing a precise size.
The study · 1
von Wernsdorff et al. 2021, Sci Rep · Sci Rep
A placebo released the brain's own dopamine in Parkinson's disease
When Parkinson's patients thought they were getting their real drug, their brains released dopamine, the very chemical the disease lacks, just from expecting to improve.
Using positron emission tomography with raclopride to index dopamine release, researchers found that placebo administration in patients with Parkinson's disease produced marked release of endogenous dopamine in the dorsal and ventral striatum. The response was linked to the patients' expectation of therapeutic benefit and to activity in reward circuitry. It is a small mechanistic imaging study, and it provided direct biological evidence that a placebo response engages a specific, disease-relevant neurochemical system.
The study · 1
Placebo effects are real psychobiological events, several mechanisms not one
The experts who pull the whole field together conclude the placebo effect is real biology, driven by expectation and learning, working through several brain systems, and that it differs from condition to condition.
Two major reviews consolidate the field. A Lancet review describes placebo effects as psychobiological events attributable to the therapeutic context, produced by expectation and by classical conditioning, and cautions that they are not a nuisance to be dismissed (Finniss 2010). A Nature Reviews Neuroscience review maps the neuroscience: how context and learning shape health outcomes, the opioid and dopamine systems involved, individual variation, and the nocebo counterpart (Wager 2015). Both frame placebo as several mechanistically distinct processes, not one uniform effect.
The studies · 2
Finniss et al. 2010, Lancet · Lancet
Wager & Atlas 2015, Nat Rev Neurosci · Nat Rev Neurosci
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Nocebo: negative expectation produces real symptoms and worsens pain
Expecting harm can cause real symptoms. Being warned a treatment may cause pain or nausea makes those symptoms more likely and more intense, through the same brain systems that drive the placebo effect.
Reviews of the placebo literature document the nocebo counterpart: verbal suggestion of a negative outcome, or prior negative experience, produces symptom worsening, including increased pain (hyperalgesia), nausea and fatigue, with measurable changes in cholecystokinin, dopaminergic and other pathways. A practical consequence is that a large fraction of the adverse effects reported by patients on active medication also appear in the placebo arms of trials, indicating an expectation-driven component. The nocebo effect shows the mechanism is bidirectional.
The studies · 2
Wager & Atlas 2015, Nat Rev Neurosci · Nat Rev Neurosci
Finniss et al. 2010, Lancet · Lancet
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Nocebo accounts for about 90% of statin side-effect burden (SAMSON crossover trial)
People who had quit statins over side effects took the real drug, a dummy pill, and nothing in random months. Their symptoms were nearly as bad on the dummy pill as on the statin, so about 90% of what they blamed on the drug also happened on the placebo.
The SAMSON trial gave 60 participants who had abandoned statins twelve one-month bottles: four of atorvastatin 20 mg, four of placebo, and four empty, in random order, with daily symptom intensity logged in an app. Forty-nine completed the 12-month protocol. Symptom scores were much higher than baseline both on the statin (16.3) and on the placebo (15.4) than in no-tablet months (8.0), and the statin and placebo did not differ (P=0.388), giving a nocebo ratio of 0.90. Neither the intensity of symptoms on starting nor their relief on stopping distinguished statin from placebo. Six months after the trial, half the participants had restarted statins. It shows most of the symptoms attributed to a real drug can be nocebo, driven by expectation rather than the chemical.
Who this may not transfer to:Enrolled adults of both sexes who had stopped statins over side effects; the nocebo mechanism is not thought to be sex-specific.
The studies · 2
Howard et al. 2021, J Am Coll Cardiol · J Am Coll Cardiol
Wood et al. 2020, N Engl J Med · N Engl J Med
Digestion
Open-label placebo eased IBS more than no treatment (5.0 vs 3.9 improvement score)
People who were told plainly their pills were placebos, with no drug in them, still felt noticeably better than people given nothing, over three weeks with a hard-to-treat gut condition.
A randomized controlled trial in 80 patients with irritable bowel syndrome compared an open-label placebo, presented openly as inert pills with an explanation that placebos can produce powerful mind-body self-healing effects, against a no-treatment control receiving the same clinician attention. After three weeks the open-label placebo group scored significantly higher on the IBS Global Improvement Scale (5.0 vs 3.9, p=0.002) and were more likely to report adequate symptom relief (59% vs 35%). It is a small, short trial in a symptom that reports subjectively, and it is the foundational demonstration that placebo effects do not require deception.
The study · 1
Kaptchuk et al. 2010, PLoS One · PLoS One
Pain
Open-label placebo cut chronic back pain about 30% on top of usual care
People with long-term back pain who added a pill they were told was a placebo, on top of their normal care, had less pain and could do more than those on normal care alone, over three weeks.
A randomized controlled trial in 97 patients with chronic low back pain compared three weeks of open-label placebo added to treatment as usual against treatment as usual alone. The open-label placebo, presented openly as inert, produced significant reductions in composite pain (about 30% in both usual and maximum pain) and in Roland-Morris disability, compared with little change in the usual-care arm. A follow-up in which the control group later crossed over to open-label placebo saw similar improvements. It is a small, short trial with self-reported outcomes.
The study · 1
Carvalho et al. 2016, Pain · Pain
Energy And Fatigue
Open-label placebo eased cancer-related fatigue about 29%
Cancer survivors who took a pill openly labeled as a placebo felt less worn out and coped better than those given no extra treatment, over three weeks.
A randomized controlled trial in 74 cancer survivors with persistent fatigue compared three weeks of open-label placebo against treatment as usual. The placebo group reported significantly greater improvement in fatigue severity (about 29%) and in fatigue-disrupted quality of life. Control participants who then took open-label placebo for three weeks showed comparable gains. The trial is small and short, and fatigue is a subjective outcome, but it extends the open-label placebo finding to a distressing symptom in a serious illness.
The study · 1
Hoenemeyer et al. 2018, Sci Rep · Sci Rep
Immune Function
The immune system learned to suppress itself on a conditioned cue
People who took an immune-suppressing drug several times alongside an unusual-tasting drink later had their immune activity drop from the drink by itself. Their bodies had learned the response.
In a controlled experiment, healthy men received the immunosuppressant drug ciclosporin A together with a novel-tasting drink over an initial learning phase. On later re-exposure to the drink alone, without the drug, they showed suppressed immune function, including reduced interleukin-2 and interferon-gamma mRNA expression and reduced lymphocyte proliferation, compared with controls. This demonstrates that a placebo response can be conditioned into the immune system, one of the two core mechanisms (alongside expectation) behind placebo effects.
Who this may not transfer to:The immune-conditioning trial enrolled only men; the conditioning mechanism is not thought to be sex-specific, but it was not measured in women.
The study · 1
Goebel et al. 2002, FASEB J · FASEB J
How It Works
The placebo effect runs on measurable biology through expectation and conditioning, and its routes have been traced in detail.
How a Placebo Acts on the Body
1Expectation activates the brain
Expecting relief switches on specific brain systems that then act on the body. Believing a treatment will help is enough to change what the nervous system does next, which is why the pill, the attention and the setting carry weight, and why a positive explanation lands differently from a doubtful one.
2The pain relief runs on the body's own opioids
For pain, expectation recruits the body's own opioids, the endogenous opioids. Naloxone, a drug that blocks opioid receptors, cancels much of placebo pain relief, and functional imaging shows placebo analgesia using the same descending pain-control pathway, from the anterior cingulate through the periaqueductal gray to the brainstem, that opioid drugs use.
3Parkinson's shows dopamine released on demand
In Parkinson's disease, a placebo the person believes is their medication triggers a release of dopamine in the striatum, the neurotransmitter the disease depletes, measured directly on a PET scan and tied to the expectation of getting better.
4The body can learn a response
Conditioning is the second route. Healthy volunteers who repeatedly took an immune-suppressing drug alongside a distinctive drink later showed immune suppression from the drink alone, the body having learned the response. Expectation and learning together, not one vague force, are what the reviews describe.
The clinical encounter is where these routes meet ordinary care. A calm, attentive practitioner and a clear, positive account of what a treatment will do raise expectation; a rushed or alarming one lowers it. How a treatment is framed changes its effect in the body.
The Nocebo Side
The nocebo effect is the same mechanism running in reverse: a negative expectation producing symptoms. Being warned that a treatment may cause nausea, pain or fatigue makes those symptoms more likely and more intense, through the same brain and hormone systems that drive the placebo response.
The clearest measure comes from statins. In a blinded crossover trial, 60 people who had stopped statins over side effects took atorvastatin, a placebo, and nothing across random months while rating their symptoms daily. Symptom scores were much higher on the statin than in the no-tablet months, and just as high on the placebo, with no difference between the drug and the dummy pill. About 90% of the symptom burden people blamed on the statin also appeared on the placebo. This is why a large share of the side effects reported on any drug also show up in the placebo arms of its trials. The same mechanism that eases symptoms can also produce them, so the way a treatment's risks are described changes how many symptoms appear.
What This Means For You
Expectation and the ritual of treatment are part of how nearly every therapy works, so the setting shapes the outcome.
- A treatment you trust, taken as a deliberate act with attention paid to it, gives its active part the best chance to work and adds an effect of its own.
- Open-label placebo shows the benefit survives being told the pill is inert, so there is nothing to fake and nothing to hide.
- The nocebo side sets a duty for clinicians and for anyone passing on health information. Reeling off every possible side effect in an alarming way can produce the symptoms it names, so framing risks accurately and calmly reduces avoidable harm.
None of this replaces an effective treatment. A placebo moves how a person feels and functions, which matters, but it does not treat the disease underneath, and it is not a reason to stop something that works. Calling a benefit "just placebo" is a category error, because the placebo effect is a documented self-healing response with effects on pain, mood, movement and the immune system. The useful questions are how much of a benefit is specific to the treatment, whether that matters for the outcome at hand, and whether the practice is safe and worth doing.
Go Deeper
This page describes a mechanism that sits underneath the whole of this section. The pages that read practices through it, or turn on it:
- How we grade evidence and why we built this, for how a claim's strength is set and the two-lens stance the placebo question forces.
- Depression, irritable bowel syndrome and chronic low back pain, the three conditions where the placebo evidence on this page was measured.
- Yang Sheng, the frame that holds tradition and evidence together without letting one rule the other.
The Chinese Medicine View
Common Questions
Is the placebo effect real or is it just in my head?
It is real, and it runs through the brain in the literal sense. A placebo response releases dopamine in Parkinson's disease, engages the body's own opioids against pain, and eases symptoms like irritable bowel and fatigue. It is your own healing systems switching on in response to expectation and the ritual of being treated, measurable in the nervous, endocrine and immune systems, not imagination and not a report given to please the researcher.
Does a placebo work if you know it is a placebo?
Yes, in several trials it does. People given a pill openly described as inert, with an explanation that placebos can act through mind-body pathways, improved more than untreated people in irritable bowel syndrome, chronic low back pain and cancer-related fatigue, and pooling 11 such trials gave a significant overall effect. Deception is not the active part. Expectation and the ritual of treatment work with the truth on the table.
Can a placebo shrink a tumor or cure a disease?
No, and this is the limit of the effect. Placebo moves symptoms and subjective states, the things the brain generates and modulates, such as pain, nausea, fatigue and mood. It does not shrink tumors, lower blood sugar, or heal a fracture. It can make someone with a serious illness feel and function better, which is worth having, but it does not treat the disease itself, and it is not a reason to stop one that works.
What is the nocebo effect?
Nocebo is the placebo effect in reverse: a negative expectation producing symptoms. Being warned that a treatment may cause pain, nausea or fatigue makes those symptoms more likely and more intense, through the same brain and hormone systems. In one crossover trial, people who had quit statins took the drug, a placebo and nothing across random months, and about 90% of the symptoms they blamed on the statin also appeared on the placebo. It is why how a treatment is described is never a neutral act.
Is acupuncture just placebo?
The fair answer is that the question is the wrong shape. Trials that compare real acupuncture with a sham needle often find both help more than no treatment, and the gap between real and sham is usually small and varies by condition, which tells you a placebo component is at work. That does not empty acupuncture of value, because the placebo response is itself an effect of the body, and it does not settle whether needling has specific effects on top, which is measured separately and case by case. Calling it "just placebo" assumes placebo is nothing, and the whole of this page is that placebo is an effect of the body.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 15 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 10, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.